The Evolution of Epigenetic Biomarkers: Methylation and similar DNA biomarkers, combined with liquid biopsy, may offer better testing options for difficult cancers

Research output: Other contribution

Abstract

At a Glance

Tissue biopsies serve a valuable purpose – but they are far from perfect
Liquid biopsy may be a better option, if we can overcome its technical limitations
Ovarian cancer is one disease that can benefit from better biomarkers and better assays
Epigenetic biomarkers, such as methylation, may improve sensitivity and specificity in the diagnosis of ovarian cancer
Original languageEnglish
PublisherThe Pathologist
Publication statusPublished - 02 Jan 2019

Fingerprint

DNA Methylation
Epigenomics
Biomarkers
Biopsy
Ovarian Neoplasms
Methylation
Neoplasms
Sensitivity and Specificity

Cite this

@misc{2ff968afda334fe996aab681f3286228,
title = "The Evolution of Epigenetic Biomarkers: Methylation and similar DNA biomarkers, combined with liquid biopsy, may offer better testing options for difficult cancers",
abstract = "At a GlanceTissue biopsies serve a valuable purpose – but they are far from perfectLiquid biopsy may be a better option, if we can overcome its technical limitationsOvarian cancer is one disease that can benefit from better biomarkers and better assaysEpigenetic biomarkers, such as methylation, may improve sensitivity and specificity in the diagnosis of ovarian cancer",
author = "Buckley, {Niamh E} and Laura Feeney and James Beirne and Paul Mullan",
year = "2019",
month = "1",
day = "2",
language = "English",
publisher = "The Pathologist",
type = "Other",

}

TY - GEN

T1 - The Evolution of Epigenetic Biomarkers

T2 - Methylation and similar DNA biomarkers, combined with liquid biopsy, may offer better testing options for difficult cancers

AU - Buckley, Niamh E

AU - Feeney, Laura

AU - Beirne, James

AU - Mullan, Paul

PY - 2019/1/2

Y1 - 2019/1/2

N2 - At a GlanceTissue biopsies serve a valuable purpose – but they are far from perfectLiquid biopsy may be a better option, if we can overcome its technical limitationsOvarian cancer is one disease that can benefit from better biomarkers and better assaysEpigenetic biomarkers, such as methylation, may improve sensitivity and specificity in the diagnosis of ovarian cancer

AB - At a GlanceTissue biopsies serve a valuable purpose – but they are far from perfectLiquid biopsy may be a better option, if we can overcome its technical limitationsOvarian cancer is one disease that can benefit from better biomarkers and better assaysEpigenetic biomarkers, such as methylation, may improve sensitivity and specificity in the diagnosis of ovarian cancer

M3 - Other contribution

PB - The Pathologist

ER -